Sangamo Therapeutics, Inc.
DELIVERY OF TARGET SPECIFIC NUCLEASES
Last updated:
Abstract:
Described herein are lipid nanoparticles comprising cationic lipids and other lipids and also comprising engineered nucleases facilitate transfer of nucleic acids to cells.
Status:
Application
Type:
Utility
Filling date:
15 May 2019
Issue date:
5 Dec 2019